Effect of Control-released Basic Fibroblast Growth Factor Incorporated in β-Tricalcium Phosphate for Murine Cranial Model

Effect of Control-released Basic Fibroblast Growth Factor Incorporated in β-Tricalcium Phosphate for Murine Cranial Model

Background: β-Tricalcium phosphate (β-TCP) is used clinically as a bone substitute, but complete osteoinduction is slow. Basic fibroblast growth factor (bFGF) is important in bone regeneration, but the biological effects are very limited because of the short half-life of the free form. Incorporation...

Full description

Bibliographic Details
Main Authors: Azusa Shimizu, MD, Satoshi Tajima, DDS, Morikuni Tobita, DDS, Rica Tanaka, MD, PhD, Yasuhiko Tabata, PhD, DMedSc, DPharm, Hiroshi Mizuno, MD
Format: Article
Language:English
Published: Wolters Kluwer 2014-03-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/Fulltext/2014/03000/Article.9.aspx

Similar Items

Similar Items